Neumora Therapeutics, Inc. Made Big Gain
Tue, Jun 16, 2026 at 07:44 PM
Neumora Therapeutics, Inc. (NMRA:NASDAQ) jumped higher at $1.56, representing a gain of 70.6%. The stock appeared on our News Catalysts scanner on Mon, Jun 15, 2026 at 09:25 AM in the 'BIOTECH' category. From Tue, Jun 02, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Feb 18, 2026 at $3.65 with a volume of 1M+.
About Neumora Therapeutics, Inc. (NMRA:NASDAQ)
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases.
Top 10 Gainers:
- SL Science Holding Limited (SLBT:NASDAQ), 166.97%
- TG-17 Inc. (OBAI:NASDAQ), 107.63%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 89.89%
- CervoMed Inc. (CRVO:NASDAQ), 82.26%
- Neumora Therapeutics, Inc. (NMRA:NASDAQ), 70.59%
- Open Lending Corporation (LPRO:NASDAQ), 48.1%
- Scilex Holding Company (SCLX:NASDAQ), 47.92%
- Fathom Holdings Inc. (FTHM:NASDAQ), 43.8%
- RTB Digital Inc Com Par $0.001 (New) (RTB:NASDAQ), 40.48%
- Dreamland Limited (TDIC:NASDAQ), 39.96%